Catalyst Wire Dossier Catalyst Wire Dossier

Tegavivint

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Tegavivint, covering 2025-12-09 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma [Phase 1, Phase 2]

See pricing